As 340B Grows More Complex, Covered Entities Need Clearer Visibility Across Vendor Relationships, Contract Pharmacy Arrangements, Manufacturer Restrictions, Referral Activity, and Emerging IRA/MFP ...
In recent weeks, two competing visions have emerged to legislatively modernize the federal 340B drug discount program (“340B Program”). The 340B Program requires manufacturers whose drugs are ...
The share of Medicare Part D claims eligible for discounts in the 340B drug pricing program increased from 1.7 percent to 9.6 percent between 2013 and 2020, a study published in JAMA Health Forum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results